八宝哮咳散合六味地黄丸治疗咳嗽变异性哮喘35例

傅小达; 李翠玲; 傅小建

您当前的位置：

首页 >

文章列表页 >

八宝哮咳散合六味地黄丸治疗咳嗽变异性哮喘35例

更新时间：2024-09-23

- 八宝哮咳散合六味地黄丸治疗咳嗽变异性哮喘35例
- Clinical Efficacy of Babao Xiaokesan plus Liuwei Dihuangwan for Treating 35 Patients Suffered from Cough Variant Asthma
- 中国实验方剂学杂志 2011年17卷第4期页码：199-202
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：
  中图分类号：
- 纸质出版日期：2011
- 稿件说明：
移动端阅览
傅小达, 李翠玲, 傅小建. 八宝哮咳散合六味地黄丸治疗咳嗽变异性哮喘35例[J]. 中国实验方剂学杂志, 2011,17(4):199-202.

FU Xiao-da, LI Cui-ling, FU Xiao-jian. Clinical Efficacy of Babao Xiaokesan plus Liuwei Dihuangwan for Treating 35 Patients Suffered from Cough Variant Asthma[J]. Chinese journal of experimental traditional medical formulae, 2011, 17(4): 199-202.
傅小达, 李翠玲, 傅小建. 八宝哮咳散合六味地黄丸治疗咳嗽变异性哮喘35例[J]. 中国实验方剂学杂志, 2011,17(4):199-202. DOI：

FU Xiao-da, LI Cui-ling, FU Xiao-jian. Clinical Efficacy of Babao Xiaokesan plus Liuwei Dihuangwan for Treating 35 Patients Suffered from Cough Variant Asthma[J]. Chinese journal of experimental traditional medical formulae, 2011, 17(4): 199-202. DOI：

摘要

目的 :观察八宝哮咳散合六味地黄丸治疗咳嗽变异性哮喘(CVA)的临床疗效。方法 :35例CVA患者均口服八宝哮咳散和六味地黄丸进行治疗。结果 :35例CVA患者中

临床治愈23例

显效9例

好转2例

无效1例

总有效率为97.1%。结论 :八宝哮咳散合六味地黄丸治疗咳嗽变异性哮喘

具有很好的疗效

且无明显不良反应。

Abstract

Objective: Toinvestigate the clinical effects on the tratment for cough variant asthma (CVA)by Babao Xiaokesan plus Liuwei Dihuangwan. Method: Thirty-five patients suffered from cough variant asthma were received the treatment of Babao Xiaokesan plus Liuwei Dihuangwan. Result: Among the 35 CVA patients

23 cases were clinically cured

9 cases were markedly effective

2 cases were effective

1 case was non-effective.The total effective rate was 97.1%. Conclusion: Babao Xiaokesan plus Liuwei Dihuangwan is a very effective therapy for the treatment of cough variant asthma.

关键词

Keywords

references

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

八宝哮咳散合六味地黄丸治疗咳嗽变异性哮喘35例

基于巨噬细胞吞噬功能探讨六味地黄丸、二至丸、左归丸预防乳腺癌发生的机制

六味地黄丸定量分析方法和评价体系的建立

咳嗽变异性哮喘风伏阴伤证大鼠模型建立与评价

中医药调节免疫平衡治疗咳嗽变异性哮喘研究进展